Novo says Wegovy injection lowers BMI and obesity rates in children in trial

Source: CNBC Markets ·

Wegovy is already approved to treat obesity in children ages 12 and older, but there are currently no approved medications for those under 12.

Read the full story at CNBC Markets

Shared from the GodsView world desk: live wires next to a globe of flights, ships, fires, and quakes.

More from the world desk